0.0497
0.0000
(0.00%)
At close: January 29 at 3:00:00 PM EST
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Michelle Miller BSc., GCertAppFin, MSc., Ph.D. | MD & Executive Director | 240.99k | -- | -- |
| Mr. Peter James Nightingale B.Econ, CA | Company Secretary | 75.04k | -- | 1957 |
Biotron Limited
56 Delhi Road
Suite 3.3 North Ryde
Sydney, NSW 2113
Australia
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in 1999 and is based in Sydney, Australia.
Corporate Governance
Biotron Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
February 25, 2025 at 10:59 AM UTC - March 3, 2025 at 12:00 PM UTC
Biotron Limited Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
PMRA.BE Pharma Mar SA
85.10
-1.10%
7ZA.F Ascelia Pharma AB
0.1726
-22.43%
INNMF Amplia Therapeutics Limited
0.0450
0.00%
22Z.BE Zealand Pharma A/S
98.45
+0.87%
SCPS Scopus BioPharma Inc.
0.0003
0.00%
BIOAF Bioasis Technologies Inc.
0.0002
0.00%
CLABF Core One Labs Inc.
0.0366
-18.67%
KLDO Kaleido Biosciences, Inc.
0.0001
0.00%
WSNAF Wesana Health Holdings Inc.
0.0685
0.00%
BETRF BetterLife Pharma Inc.
0.1140
0.00%